#United States #New York #Levi & Korsinsky #AstraZeneca #securities lawsuit

Class Action Alert: AstraZeneca PLC

Levi & Korsinsky, LLP, a law firm specializing in securities litigation, has officially notified investors of AstraZeneca PLC (NASDAQ: AZN) regarding a class action lawsuit. This lawsuit comes as a response to allegations of securities fraud that occurred between February 23, 2022, and December 17, 2024.

Understanding the Allegations

The core of the lawsuit centers around claims that AstraZeneca engaged in fraudulent activities in China, which purportedly led to significant legal repercussions and operational risks. The following allegations have been made against the company:
1. Insurance Fraud: It is alleged that AstraZeneca took part in insurance fraud within the Chinese market.
2. Legal Exposure: Due to these actions, the company faced increased legal scrutiny that resulted in the detainment of its China President by local authorities.
3. Understated Risks: AstraZeneca is accused of downplaying its legal exposure, misleading investors regarding the potential risks associated with its operations in China.
4. Impact on Business: The revelations could severely tarnish AstraZeneca’s business activities in the region.
5. Misleading Statements: The company's previous statements about its business outlook and operational capabilities are claimed to be materially false and misleading.

Important Dates to Note

If you are an investor who has suffered financial losses due to these allegations during the specified time frame, you are encouraged to act swiftly. The cutoff date to apply for lead plaintiff status is February 21, 2025. However, you do not need to act as a lead plaintiff to partake in any potential recovery from the class action settlement.

No Financial Risk to Participants

Participating in this class action comes at no cost to members. Should you qualify as a class member, compensation could be available without requiring you to pay any out-of-pocket fees. The firm reiterates its commitment to ensuring that investors are informed without incurring financial burden.

Why Levi & Korsinsky?

With over 20 years of experience, Levi & Korsinsky has developed a strong reputation for advocating on behalf of shareholders. The firm has successfully recovered hundreds of millions for clients over the years and has been recognized as a leading entity in securities class actions, appearing in ISS Securities Class Action Services' Top 50 for seven consecutive years. Their extensive experience offers an assurance to investors looking for representation in complex securities litigation cases.

How to Reach Out

If you are interested in learning more about your rights as an affected investor or how to get involved, you can contact Levi & Korsinsky directly. Reach out to:

• - Joseph E. Levi, Esq. via email at email protected] or by phone at (212) 363-7500.
• - Additional details can be found by visiting their website at [www.zlk.com.

This class action represents a significant opportunity for impacted investors to reclaim damages associated with their investments in AstraZeneca. Staying informed and proactive is crucial for those eligible to participate.